What is the appropriate dose of Ceftriaxone (Ceftriaxone) for a 4-year-old female patient weighing 18.9 kg with pyelonephritis, and is 100mg/kg acceptable?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for Pediatric Pyelonephritis

For a 4-year-old female weighing 18.9 kg with pyelonephritis, 100 mg/kg/day of ceftriaxone is excessive and not recommended—the appropriate dose is 50-75 mg/kg/day (approximately 950-1,420 mg/day for this patient), given once daily or divided every 12-24 hours. 1, 2

Standard Pediatric Dosing Algorithm

For infants and children beyond the neonatal period with pyelonephritis:

  • Standard dose: 50-75 mg/kg/day given once daily or divided every 12-24 hours 1, 2
  • For this 18.9 kg patient: 945-1,418 mg/day (practical dosing would be 1,000 mg once daily)
  • Maximum daily dose: 2 grams for non-meningeal infections 2

Why 100 mg/kg Is Not Appropriate

The 100 mg/kg/day dosing is reserved for specific severe infections, NOT routine pyelonephritis:

  • Bacterial meningitis: 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 2
  • Severe pneumonia with documented penicillin-resistant pneumococcus: 100 mg/kg/day 2
  • Gram-negative enteric bacilli with CNS involvement: 100 mg/kg/day 2

For uncomplicated pyelonephritis, even if severe, the standard 50-75 mg/kg/day range is appropriate and effective. 1, 2

Evidence Supporting Standard Dosing for Pyelonephritis

Clinical studies demonstrate excellent efficacy with standard dosing:

  • A prospective study of 34 children with acute pyelonephritis used 50 mg/kg/day (maximum 2 g/day) with successful eradication in all cases 3
  • Comparative study showed once-daily ceftriaxone was superior to twice-daily cefotaxime for childhood upper UTIs, with better cure rates and fewer recurrences 4
  • The once-daily dosing advantage makes ceftriaxone particularly attractive for pediatric pyelonephritis compared to other agents requiring multiple daily doses 4

Practical Dosing Recommendation

For this 18.9 kg patient with pyelonephritis:

  • Recommended dose: 1,000 mg (approximately 53 mg/kg) IV/IM once daily 1, 2
  • Alternative: 500 mg IV every 12 hours (total 1,000 mg/day) 1, 2
  • Duration: 7-10 days based on clinical response 3, 4

Important Safety Consideration

Reversible biliary pseudolithiasis can occur even with standard dosing:

  • Gallbladder precipitates developed in 15% of children receiving 50 mg/kg/day for pyelonephritis after only 3-5 doses 3
  • All cases were asymptomatic and resolved spontaneously 2-5 months after discontinuation 3
  • This is not a contraindication to use, but clinicians should be aware to prevent unnecessary anxiety or cholecystectomy 3
  • The antibacterial and pharmacokinetic benefits outweigh this reversible complication 3

Common Pitfall to Avoid

Do not extrapolate meningitis dosing (100 mg/kg/day) to other infections. The higher dose is specifically for achieving adequate CNS penetration and treating resistant organisms in the central nervous system. 2 For pyelonephritis, standard dosing provides excellent urinary and tissue concentrations without the need for higher doses that increase the risk of adverse effects including biliary sludging. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Dosing of Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.